[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Immunohistochemistry (IHC) Antibody Market Growth 2023-2029

May 2023 | 116 pages | ID: GAD7DE7881EAEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Immunohistochemistry (IHC) Antibody market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Immunohistochemistry (IHC) Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Immunohistochemistry (IHC) Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Immunohistochemistry (IHC) Antibody is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Immunohistochemistry (IHC) Antibody players cover Merck, Bio-Techne, BD Biosciences, Thermo Fisher Scientific, Amoy Diagnostics, Sino Biological, ACROBiosystems, Roche Holding and Lifespan Biosciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Immunohistochemistry (IHC) Antibody Industry Forecast” looks at past sales and reviews total world Immunohistochemistry (IHC) Antibody sales in 2022, providing a comprehensive analysis by region and market sector of projected Immunohistochemistry (IHC) Antibody sales for 2023 through 2029. With Immunohistochemistry (IHC) Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Immunohistochemistry (IHC) Antibody industry.

This Insight Report provides a comprehensive analysis of the global Immunohistochemistry (IHC) Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Immunohistochemistry (IHC) Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Immunohistochemistry (IHC) Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Immunohistochemistry (IHC) Antibody and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Immunohistochemistry (IHC) Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of Immunohistochemistry (IHC) Antibody market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
  • Monoclonal Antibody
  • Polyclonal Antibody
Segmentation by application
  • Medical Research
  • Biological Test
  • Pathological Diagnosis
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Merck
  • Bio-Techne
  • BD Biosciences
  • Thermo Fisher Scientific
  • Amoy Diagnostics
  • Sino Biological
  • ACROBiosystems
  • Roche Holding
  • Lifespan Biosciences
  • Creative Biolabs
  • Boster Bio
  • GenomeMe
  • Leinco Technologies
  • Covalab
  • BIOTEM
  • Jackson ImmunoResearch
  • INNOVEX Biosciences
Key Questions Addressed in this Report

What is the 10-year outlook for the global Immunohistochemistry (IHC) Antibody market?

What factors are driving Immunohistochemistry (IHC) Antibody market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Immunohistochemistry (IHC) Antibody market opportunities vary by end market size?

How does Immunohistochemistry (IHC) Antibody break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Immunohistochemistry (IHC) Antibody Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Immunohistochemistry (IHC) Antibody by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Immunohistochemistry (IHC) Antibody by Country/Region, 2018, 2022 & 2029
2.2 Immunohistochemistry (IHC) Antibody Segment by Type
  2.2.1 Monoclonal Antibody
  2.2.2 Polyclonal Antibody
2.3 Immunohistochemistry (IHC) Antibody Sales by Type
  2.3.1 Global Immunohistochemistry (IHC) Antibody Sales Market Share by Type (2018-2023)
  2.3.2 Global Immunohistochemistry (IHC) Antibody Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Immunohistochemistry (IHC) Antibody Sale Price by Type (2018-2023)
2.4 Immunohistochemistry (IHC) Antibody Segment by Application
  2.4.1 Medical Research
  2.4.2 Biological Test
  2.4.3 Pathological Diagnosis
  2.4.4 Others
2.5 Immunohistochemistry (IHC) Antibody Sales by Application
  2.5.1 Global Immunohistochemistry (IHC) Antibody Sale Market Share by Application (2018-2023)
  2.5.2 Global Immunohistochemistry (IHC) Antibody Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Immunohistochemistry (IHC) Antibody Sale Price by Application (2018-2023)

3 GLOBAL IMMUNOHISTOCHEMISTRY (IHC) ANTIBODY BY COMPANY

3.1 Global Immunohistochemistry (IHC) Antibody Breakdown Data by Company
  3.1.1 Global Immunohistochemistry (IHC) Antibody Annual Sales by Company (2018-2023)
  3.1.2 Global Immunohistochemistry (IHC) Antibody Sales Market Share by Company (2018-2023)
3.2 Global Immunohistochemistry (IHC) Antibody Annual Revenue by Company (2018-2023)
  3.2.1 Global Immunohistochemistry (IHC) Antibody Revenue by Company (2018-2023)
  3.2.2 Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Company (2018-2023)
3.3 Global Immunohistochemistry (IHC) Antibody Sale Price by Company
3.4 Key Manufacturers Immunohistochemistry (IHC) Antibody Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Immunohistochemistry (IHC) Antibody Product Location Distribution
  3.4.2 Players Immunohistochemistry (IHC) Antibody Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR IMMUNOHISTOCHEMISTRY (IHC) ANTIBODY BY GEOGRAPHIC REGION

4.1 World Historic Immunohistochemistry (IHC) Antibody Market Size by Geographic Region (2018-2023)
  4.1.1 Global Immunohistochemistry (IHC) Antibody Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Immunohistochemistry (IHC) Antibody Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Immunohistochemistry (IHC) Antibody Market Size by Country/Region (2018-2023)
  4.2.1 Global Immunohistochemistry (IHC) Antibody Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Immunohistochemistry (IHC) Antibody Annual Revenue by Country/Region (2018-2023)
4.3 Americas Immunohistochemistry (IHC) Antibody Sales Growth
4.4 APAC Immunohistochemistry (IHC) Antibody Sales Growth
4.5 Europe Immunohistochemistry (IHC) Antibody Sales Growth
4.6 Middle East & Africa Immunohistochemistry (IHC) Antibody Sales Growth

5 AMERICAS

5.1 Americas Immunohistochemistry (IHC) Antibody Sales by Country
  5.1.1 Americas Immunohistochemistry (IHC) Antibody Sales by Country (2018-2023)
  5.1.2 Americas Immunohistochemistry (IHC) Antibody Revenue by Country (2018-2023)
5.2 Americas Immunohistochemistry (IHC) Antibody Sales by Type
5.3 Americas Immunohistochemistry (IHC) Antibody Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Immunohistochemistry (IHC) Antibody Sales by Region
  6.1.1 APAC Immunohistochemistry (IHC) Antibody Sales by Region (2018-2023)
  6.1.2 APAC Immunohistochemistry (IHC) Antibody Revenue by Region (2018-2023)
6.2 APAC Immunohistochemistry (IHC) Antibody Sales by Type
6.3 APAC Immunohistochemistry (IHC) Antibody Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Immunohistochemistry (IHC) Antibody by Country
  7.1.1 Europe Immunohistochemistry (IHC) Antibody Sales by Country (2018-2023)
  7.1.2 Europe Immunohistochemistry (IHC) Antibody Revenue by Country (2018-2023)
7.2 Europe Immunohistochemistry (IHC) Antibody Sales by Type
7.3 Europe Immunohistochemistry (IHC) Antibody Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Immunohistochemistry (IHC) Antibody by Country
  8.1.1 Middle East & Africa Immunohistochemistry (IHC) Antibody Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Immunohistochemistry (IHC) Antibody Revenue by Country (2018-2023)
8.2 Middle East & Africa Immunohistochemistry (IHC) Antibody Sales by Type
8.3 Middle East & Africa Immunohistochemistry (IHC) Antibody Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Immunohistochemistry (IHC) Antibody
10.3 Manufacturing Process Analysis of Immunohistochemistry (IHC) Antibody
10.4 Industry Chain Structure of Immunohistochemistry (IHC) Antibody

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Immunohistochemistry (IHC) Antibody Distributors
11.3 Immunohistochemistry (IHC) Antibody Customer

12 WORLD FORECAST REVIEW FOR IMMUNOHISTOCHEMISTRY (IHC) ANTIBODY BY GEOGRAPHIC REGION

12.1 Global Immunohistochemistry (IHC) Antibody Market Size Forecast by Region
  12.1.1 Global Immunohistochemistry (IHC) Antibody Forecast by Region (2024-2029)
  12.1.2 Global Immunohistochemistry (IHC) Antibody Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Immunohistochemistry (IHC) Antibody Forecast by Type
12.7 Global Immunohistochemistry (IHC) Antibody Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Merck
  13.1.1 Merck Company Information
  13.1.2 Merck Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.1.3 Merck Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 Merck Main Business Overview
  13.1.5 Merck Latest Developments
13.2 Bio-Techne
  13.2.1 Bio-Techne Company Information
  13.2.2 Bio-Techne Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.2.3 Bio-Techne Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Bio-Techne Main Business Overview
  13.2.5 Bio-Techne Latest Developments
13.3 BD Biosciences
  13.3.1 BD Biosciences Company Information
  13.3.2 BD Biosciences Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.3.3 BD Biosciences Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 BD Biosciences Main Business Overview
  13.3.5 BD Biosciences Latest Developments
13.4 Thermo Fisher Scientific
  13.4.1 Thermo Fisher Scientific Company Information
  13.4.2 Thermo Fisher Scientific Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.4.3 Thermo Fisher Scientific Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Thermo Fisher Scientific Main Business Overview
  13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Amoy Diagnostics
  13.5.1 Amoy Diagnostics Company Information
  13.5.2 Amoy Diagnostics Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.5.3 Amoy Diagnostics Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Amoy Diagnostics Main Business Overview
  13.5.5 Amoy Diagnostics Latest Developments
13.6 Sino Biological
  13.6.1 Sino Biological Company Information
  13.6.2 Sino Biological Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.6.3 Sino Biological Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 Sino Biological Main Business Overview
  13.6.5 Sino Biological Latest Developments
13.7 ACROBiosystems
  13.7.1 ACROBiosystems Company Information
  13.7.2 ACROBiosystems Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.7.3 ACROBiosystems Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 ACROBiosystems Main Business Overview
  13.7.5 ACROBiosystems Latest Developments
13.8 Roche Holding
  13.8.1 Roche Holding Company Information
  13.8.2 Roche Holding Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.8.3 Roche Holding Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Roche Holding Main Business Overview
  13.8.5 Roche Holding Latest Developments
13.9 Lifespan Biosciences
  13.9.1 Lifespan Biosciences Company Information
  13.9.2 Lifespan Biosciences Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.9.3 Lifespan Biosciences Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Lifespan Biosciences Main Business Overview
  13.9.5 Lifespan Biosciences Latest Developments
13.10 Creative Biolabs
  13.10.1 Creative Biolabs Company Information
  13.10.2 Creative Biolabs Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.10.3 Creative Biolabs Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 Creative Biolabs Main Business Overview
  13.10.5 Creative Biolabs Latest Developments
13.11 Boster Bio
  13.11.1 Boster Bio Company Information
  13.11.2 Boster Bio Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.11.3 Boster Bio Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.11.4 Boster Bio Main Business Overview
  13.11.5 Boster Bio Latest Developments
13.12 GenomeMe
  13.12.1 GenomeMe Company Information
  13.12.2 GenomeMe Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.12.3 GenomeMe Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.12.4 GenomeMe Main Business Overview
  13.12.5 GenomeMe Latest Developments
13.13 Leinco Technologies
  13.13.1 Leinco Technologies Company Information
  13.13.2 Leinco Technologies Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.13.3 Leinco Technologies Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.13.4 Leinco Technologies Main Business Overview
  13.13.5 Leinco Technologies Latest Developments
13.14 Covalab
  13.14.1 Covalab Company Information
  13.14.2 Covalab Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.14.3 Covalab Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.14.4 Covalab Main Business Overview
  13.14.5 Covalab Latest Developments
13.15 BIOTEM
  13.15.1 BIOTEM Company Information
  13.15.2 BIOTEM Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.15.3 BIOTEM Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.15.4 BIOTEM Main Business Overview
  13.15.5 BIOTEM Latest Developments
13.16 Jackson ImmunoResearch
  13.16.1 Jackson ImmunoResearch Company Information
  13.16.2 Jackson ImmunoResearch Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.16.3 Jackson ImmunoResearch Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.16.4 Jackson ImmunoResearch Main Business Overview
  13.16.5 Jackson ImmunoResearch Latest Developments
13.17 INNOVEX Biosciences
  13.17.1 INNOVEX Biosciences Company Information
  13.17.2 INNOVEX Biosciences Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
  13.17.3 INNOVEX Biosciences Immunohistochemistry (IHC) Antibody Sales, Revenue, Price and Gross Margin (2018-2023)
  13.17.4 INNOVEX Biosciences Main Business Overview
  13.17.5 INNOVEX Biosciences Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Immunohistochemistry (IHC) Antibody Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Immunohistochemistry (IHC) Antibody Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Polyclonal Antibody
Table 5. Global Immunohistochemistry (IHC) Antibody Sales by Type (2018-2023) & (K Units)
Table 6. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Type (2018-2023)
Table 7. Global Immunohistochemistry (IHC) Antibody Revenue by Type (2018-2023) & ($ million)
Table 8. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Type (2018-2023)
Table 9. Global Immunohistochemistry (IHC) Antibody Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Immunohistochemistry (IHC) Antibody Sales by Application (2018-2023) & (K Units)
Table 11. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Application (2018-2023)
Table 12. Global Immunohistochemistry (IHC) Antibody Revenue by Application (2018-2023)
Table 13. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Application (2018-2023)
Table 14. Global Immunohistochemistry (IHC) Antibody Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Immunohistochemistry (IHC) Antibody Sales by Company (2018-2023) & (K Units)
Table 16. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Company (2018-2023)
Table 17. Global Immunohistochemistry (IHC) Antibody Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Company (2018-2023)
Table 19. Global Immunohistochemistry (IHC) Antibody Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Immunohistochemistry (IHC) Antibody Producing Area Distribution and Sales Area
Table 21. Players Immunohistochemistry (IHC) Antibody Products Offered
Table 22. Immunohistochemistry (IHC) Antibody Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Immunohistochemistry (IHC) Antibody Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Immunohistochemistry (IHC) Antibody Sales Market Share Geographic Region (2018-2023)
Table 27. Global Immunohistochemistry (IHC) Antibody Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Immunohistochemistry (IHC) Antibody Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Country/Region (2018-2023)
Table 31. Global Immunohistochemistry (IHC) Antibody Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Immunohistochemistry (IHC) Antibody Sales by Country (2018-2023) & (K Units)
Table 34. Americas Immunohistochemistry (IHC) Antibody Sales Market Share by Country (2018-2023)
Table 35. Americas Immunohistochemistry (IHC) Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Immunohistochemistry (IHC) Antibody Revenue Market Share by Country (2018-2023)
Table 37. Americas Immunohistochemistry (IHC) Antibody Sales by Type (2018-2023) & (K Units)
Table 38. Americas Immunohistochemistry (IHC) Antibody Sales by Application (2018-2023) & (K Units)
Table 39. APAC Immunohistochemistry (IHC) Antibody Sales by Region (2018-2023) & (K Units)
Table 40. APAC Immunohistochemistry (IHC) Antibody Sales Market Share by Region (2018-2023)
Table 41. APAC Immunohistochemistry (IHC) Antibody Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Immunohistochemistry (IHC) Antibody Revenue Market Share by Region (2018-2023)
Table 43. APAC Immunohistochemistry (IHC) Antibody Sales by Type (2018-2023) & (K Units)
Table 44. APAC Immunohistochemistry (IHC) Antibody Sales by Application (2018-2023) & (K Units)
Table 45. Europe Immunohistochemistry (IHC) Antibody Sales by Country (2018-2023) & (K Units)
Table 46. Europe Immunohistochemistry (IHC) Antibody Sales Market Share by Country (2018-2023)
Table 47. Europe Immunohistochemistry (IHC) Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Immunohistochemistry (IHC) Antibody Revenue Market Share by Country (2018-2023)
Table 49. Europe Immunohistochemistry (IHC) Antibody Sales by Type (2018-2023) & (K Units)
Table 50. Europe Immunohistochemistry (IHC) Antibody Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Immunohistochemistry (IHC) Antibody Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Immunohistochemistry (IHC) Antibody Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Immunohistochemistry (IHC) Antibody
Table 58. Key Market Challenges & Risks of Immunohistochemistry (IHC) Antibody
Table 59. Key Industry Trends of Immunohistochemistry (IHC) Antibody
Table 60. Immunohistochemistry (IHC) Antibody Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Immunohistochemistry (IHC) Antibody Distributors List
Table 63. Immunohistochemistry (IHC) Antibody Customer List
Table 64. Global Immunohistochemistry (IHC) Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Immunohistochemistry (IHC) Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Immunohistochemistry (IHC) Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Immunohistochemistry (IHC) Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Immunohistochemistry (IHC) Antibody Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Immunohistochemistry (IHC) Antibody Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Immunohistochemistry (IHC) Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Immunohistochemistry (IHC) Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Immunohistochemistry (IHC) Antibody Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Immunohistochemistry (IHC) Antibody Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Immunohistochemistry (IHC) Antibody Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Immunohistochemistry (IHC) Antibody Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Immunohistochemistry (IHC) Antibody Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Merck Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 79. Merck Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 80. Merck Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Merck Main Business
Table 82. Merck Latest Developments
Table 83. Bio-Techne Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 84. Bio-Techne Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 85. Bio-Techne Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Bio-Techne Main Business
Table 87. Bio-Techne Latest Developments
Table 88. BD Biosciences Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 89. BD Biosciences Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 90. BD Biosciences Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. BD Biosciences Main Business
Table 92. BD Biosciences Latest Developments
Table 93. Thermo Fisher Scientific Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 94. Thermo Fisher Scientific Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 95. Thermo Fisher Scientific Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Thermo Fisher Scientific Main Business
Table 97. Thermo Fisher Scientific Latest Developments
Table 98. Amoy Diagnostics Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 99. Amoy Diagnostics Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 100. Amoy Diagnostics Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Amoy Diagnostics Main Business
Table 102. Amoy Diagnostics Latest Developments
Table 103. Sino Biological Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 104. Sino Biological Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 105. Sino Biological Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Sino Biological Main Business
Table 107. Sino Biological Latest Developments
Table 108. ACROBiosystems Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 109. ACROBiosystems Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 110. ACROBiosystems Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. ACROBiosystems Main Business
Table 112. ACROBiosystems Latest Developments
Table 113. Roche Holding Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 114. Roche Holding Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 115. Roche Holding Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Roche Holding Main Business
Table 117. Roche Holding Latest Developments
Table 118. Lifespan Biosciences Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 119. Lifespan Biosciences Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 120. Lifespan Biosciences Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Lifespan Biosciences Main Business
Table 122. Lifespan Biosciences Latest Developments
Table 123. Creative Biolabs Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 124. Creative Biolabs Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 125. Creative Biolabs Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Creative Biolabs Main Business
Table 127. Creative Biolabs Latest Developments
Table 128. Boster Bio Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 129. Boster Bio Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 130. Boster Bio Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Boster Bio Main Business
Table 132. Boster Bio Latest Developments
Table 133. GenomeMe Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 134. GenomeMe Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 135. GenomeMe Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. GenomeMe Main Business
Table 137. GenomeMe Latest Developments
Table 138. Leinco Technologies Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 139. Leinco Technologies Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 140. Leinco Technologies Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Leinco Technologies Main Business
Table 142. Leinco Technologies Latest Developments
Table 143. Covalab Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 144. Covalab Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 145. Covalab Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. Covalab Main Business
Table 147. Covalab Latest Developments
Table 148. BIOTEM Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 149. BIOTEM Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 150. BIOTEM Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. BIOTEM Main Business
Table 152. BIOTEM Latest Developments
Table 153. Jackson ImmunoResearch Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 154. Jackson ImmunoResearch Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 155. Jackson ImmunoResearch Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. Jackson ImmunoResearch Main Business
Table 157. Jackson ImmunoResearch Latest Developments
Table 158. INNOVEX Biosciences Basic Information, Immunohistochemistry (IHC) Antibody Manufacturing Base, Sales Area and Its Competitors
Table 159. INNOVEX Biosciences Immunohistochemistry (IHC) Antibody Product Portfolios and Specifications
Table 160. INNOVEX Biosciences Immunohistochemistry (IHC) Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 161. INNOVEX Biosciences Main Business
Table 162. INNOVEX Biosciences Latest Developments

LIST OF FIGURES

Figure 1. Picture of Immunohistochemistry (IHC) Antibody
Figure 2. Immunohistochemistry (IHC) Antibody Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Immunohistochemistry (IHC) Antibody Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Immunohistochemistry (IHC) Antibody Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Immunohistochemistry (IHC) Antibody Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Monoclonal Antibody
Figure 10. Product Picture of Polyclonal Antibody
Figure 11. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Type in 2022
Figure 12. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Type (2018-2023)
Figure 13. Immunohistochemistry (IHC) Antibody Consumed in Medical Research
Figure 14. Global Immunohistochemistry (IHC) Antibody Market: Medical Research (2018-2023) & (K Units)
Figure 15. Immunohistochemistry (IHC) Antibody Consumed in Biological Test
Figure 16. Global Immunohistochemistry (IHC) Antibody Market: Biological Test (2018-2023) & (K Units)
Figure 17. Immunohistochemistry (IHC) Antibody Consumed in Pathological Diagnosis
Figure 18. Global Immunohistochemistry (IHC) Antibody Market: Pathological Diagnosis (2018-2023) & (K Units)
Figure 19. Immunohistochemistry (IHC) Antibody Consumed in Others
Figure 20. Global Immunohistochemistry (IHC) Antibody Market: Others (2018-2023) & (K Units)
Figure 21. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Application (2022)
Figure 22. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Application in 2022
Figure 23. Immunohistochemistry (IHC) Antibody Sales Market by Company in 2022 (K Units)
Figure 24. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Company in 2022
Figure 25. Immunohistochemistry (IHC) Antibody Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Company in 2022
Figure 27. Global Immunohistochemistry (IHC) Antibody Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Immunohistochemistry (IHC) Antibody Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Immunohistochemistry (IHC) Antibody Sales 2018-2023 (K Units)
Figure 30. Americas Immunohistochemistry (IHC) Antibody Revenue 2018-2023 ($ Millions)
Figure 31. APAC Immunohistochemistry (IHC) Antibody Sales 2018-2023 (K Units)
Figure 32. APAC Immunohistochemistry (IHC) Antibody Revenue 2018-2023 ($ Millions)
Figure 33. Europe Immunohistochemistry (IHC) Antibody Sales 2018-2023 (K Units)
Figure 34. Europe Immunohistochemistry (IHC) Antibody Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales 2018-2023 (K Units)
Figure 36. Middle East & Africa Immunohistochemistry (IHC) Antibody Revenue 2018-2023 ($ Millions)
Figure 37. Americas Immunohistochemistry (IHC) Antibody Sales Market Share by Country in 2022
Figure 38. Americas Immunohistochemistry (IHC) Antibody Revenue Market Share by Country in 2022
Figure 39. Americas Immunohistochemistry (IHC) Antibody Sales Market Share by Type (2018-2023)
Figure 40. Americas Immunohistochemistry (IHC) Antibody Sales Market Share by Application (2018-2023)
Figure 41. United States Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Immunohistochemistry (IHC) Antibody Sales Market Share by Region in 2022
Figure 46. APAC Immunohistochemistry (IHC) Antibody Revenue Market Share by Regions in 2022
Figure 47. APAC Immunohistochemistry (IHC) Antibody Sales Market Share by Type (2018-2023)
Figure 48. APAC Immunohistochemistry (IHC) Antibody Sales Market Share by Application (2018-2023)
Figure 49. China Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Immunohistochemistry (IHC) Antibody Sales Market Share by Country in 2022
Figure 57. Europe Immunohistochemistry (IHC) Antibody Revenue Market Share by Country in 2022
Figure 58. Europe Immunohistochemistry (IHC) Antibody Sales Market Share by Type (2018-2023)
Figure 59. Europe Immunohistochemistry (IHC) Antibody Sales Market Share by Application (2018-2023)
Figure 60. Germany Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Immunohistochemistry (IHC) Antibody Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Immunohistochemistry (IHC) Antibody Sales Market Share by Application (2018-2023)
Figure 69. Egypt Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Immunohistochemistry (IHC) Antibody Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Immunohistochemistry (IHC) Antibody in 2022
Figure 75. Manufacturing Process Analysis of Immunohistochemistry (IHC) Antibody
Figure 76. Industry Chain Structure of Immunohistochemistry (IHC) Antibody
Figure 77. Channels of Distribution
Figure 78. Global Immunohistochemistry (IHC) Antibody Sales Market Forecast by Region (2024-2029)
Figure 79. Global Immunohistochemistry (IHC) Antibody Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Immunohistochemistry (IHC) Antibody Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Immunohistochemistry (IHC) Antibody Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Immunohistochemistry (IHC) Antibody Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Immunohistochemistry (IHC) Antibody Revenue Market Share Forecast by Application (2024-2029)


More Publications